DK159117C - Fremgangsmaade til fremstilling af de rene enkeltfaktorer 1, 2, 3, 4 og 5 af teichomycin a2 eller farmaceutisk acceptable salte deraf - Google Patents

Fremgangsmaade til fremstilling af de rene enkeltfaktorer 1, 2, 3, 4 og 5 af teichomycin a2 eller farmaceutisk acceptable salte deraf

Info

Publication number
DK159117C
DK159117C DK245883A DK245883A DK159117C DK 159117 C DK159117 C DK 159117C DK 245883 A DK245883 A DK 245883A DK 245883 A DK245883 A DK 245883A DK 159117 C DK159117 C DK 159117C
Authority
DK
Denmark
Prior art keywords
teichomycin
preparing
procedure
acceptable salts
pharmaceutical acceptable
Prior art date
Application number
DK245883A
Other languages
Danish (da)
English (en)
Other versions
DK159117B (da
DK245883A (da
DK245883D0 (da
Inventor
Angelo Borghi
Rosa Pallanza
Carolina Coronelli
Giovanni Cassani
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of DK245883D0 publication Critical patent/DK245883D0/da
Publication of DK245883A publication Critical patent/DK245883A/da
Publication of DK159117B publication Critical patent/DK159117B/da
Application granted granted Critical
Publication of DK159117C publication Critical patent/DK159117C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/045—Actinoplanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK245883A 1982-06-08 1983-05-31 Fremgangsmaade til fremstilling af de rene enkeltfaktorer 1, 2, 3, 4 og 5 af teichomycin a2 eller farmaceutisk acceptable salte deraf DK159117C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8216590 1982-06-08
GB8216590 1982-06-08

Publications (4)

Publication Number Publication Date
DK245883D0 DK245883D0 (da) 1983-05-31
DK245883A DK245883A (da) 1983-12-09
DK159117B DK159117B (da) 1990-09-03
DK159117C true DK159117C (da) 1991-02-11

Family

ID=10530888

Family Applications (1)

Application Number Title Priority Date Filing Date
DK245883A DK159117C (da) 1982-06-08 1983-05-31 Fremgangsmaade til fremstilling af de rene enkeltfaktorer 1, 2, 3, 4 og 5 af teichomycin a2 eller farmaceutisk acceptable salte deraf

Country Status (32)

Country Link
US (1) US4542018A (xx)
JP (5) JPS591423A (xx)
KR (1) KR900008246B1 (xx)
AU (1) AU560966B2 (xx)
BE (1) BE896993A (xx)
BG (1) BG60529B2 (xx)
CA (1) CA1208204A (xx)
CH (1) CH657139A5 (xx)
DE (1) DE3320342A1 (xx)
DK (1) DK159117C (xx)
ES (2) ES522941A0 (xx)
FI (1) FI73697C (xx)
FR (1) FR2528050B1 (xx)
GB (1) GB2121401B (xx)
GR (1) GR78267B (xx)
HK (1) HK55887A (xx)
HU (1) HU193538B (xx)
IE (1) IE55025B1 (xx)
IL (1) IL68819A0 (xx)
IT (1) IT1212085B (xx)
LU (1) LU84853A1 (xx)
MY (1) MY8700002A (xx)
NL (1) NL8301980A (xx)
NO (1) NO159104C (xx)
NZ (1) NZ204480A (xx)
PH (1) PH19533A (xx)
PT (1) PT76831B (xx)
SE (1) SE459094B (xx)
SG (1) SG70686G (xx)
SU (1) SU1318170A3 (xx)
UA (1) UA6025A1 (xx)
ZA (1) ZA833607B (xx)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8307847D0 (en) * 1983-03-22 1983-04-27 Lepetit Spa Antibiotics l 17054 and l 17046
US4696817A (en) * 1983-10-11 1987-09-29 The Dow Chemical Company Extraction of teichomycin A2 from whole culture fermentation broth
GB8333624D0 (en) * 1983-12-16 1984-01-25 Lepetit Spa Antibiotics l 17054 and l 17392
GB8415093D0 (en) * 1984-06-13 1984-07-18 Lepetit Spa Antibiotic l 17392
GB8415092D0 (en) * 1984-06-13 1984-07-18 Lepetit Spa Ester derivatives
GB8428619D0 (en) * 1984-11-13 1984-12-19 Lepetit Spa Derivatives of antibiotic l 17046
GB8512795D0 (en) * 1985-05-21 1985-06-26 Lepetit Spa Increasing ratio of components of teicoplanin a2 complex
US4694069A (en) * 1985-09-30 1987-09-15 Smithkline Beckman Corporation Kibdelosporangium aridum SK&F-AAD-609
JPS61241319A (ja) * 1986-04-25 1986-10-27 Kanegafuchi Chem Ind Co Ltd 新規エーテル‐エステルブロツク共重合体を含有する室温硬化性組成物
US4845194A (en) * 1987-02-27 1989-07-04 Eli Lilly And Company Glycopeptide recovery process
GB8715735D0 (en) * 1987-07-03 1987-08-12 Lepetit Spa De-mannosyl teicoplanin derivatives
US4996148A (en) * 1987-07-13 1991-02-26 Eli Lilly And Company A80407 antibiotics
US5213797A (en) * 1987-07-13 1993-05-25 Eli Lilly And Company A80407 antibiotics
GB8720980D0 (en) * 1987-09-07 1987-10-14 Lepetit Spa Derivatives
US5194424A (en) * 1988-12-27 1993-03-16 Gruppo Lepetit Spa C63 -amide derivatives of 34-de(acetylglucosaminyl)-34-deoxy-teicoplanin and their use as medicaments against bacteria resistant to glycopeptide antibiotics
JPH06503306A (ja) * 1990-12-05 1994-04-14 グルポ・レペチツト・エス・ピー・エイ テイコプラニン抗生物質の３８−デカルボキシ−３８−ヒドロキシメチル誘導体およびそれらの製造方法
US5606036A (en) * 1991-03-27 1997-02-25 Gruppo Lepetit Spa Antibiotic A 40926 ester derivatives
ATE208791T1 (de) 1996-04-23 2001-11-15 Biosearch Italia Spa Chemisches verfahren zur herstellung von amidderivaten von a 40926 antibiotikum
KR100476818B1 (ko) * 2002-07-19 2005-03-17 종근당바이오 주식회사 테이코플라닌 에이 투 정제 방법
US20060074014A1 (en) * 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
KR101173310B1 (ko) * 2002-11-18 2012-08-10 비큐론 파마세티컬스 인코포레이티드 박테리아 감염 치료를 위한 달바반신 투여 방법
US7119061B2 (en) 2002-11-18 2006-10-10 Vicuron Pharmaceuticals, Inc. Dalbavancin compositions for treatment of bacterial infections
EP1806150A1 (en) * 2006-01-05 2007-07-11 NEED PHARMA S.r.l. Teicoplanin composition
CN102718843B (zh) * 2012-06-30 2014-05-14 华北制药集团新药研究开发有限责任公司 一种替考拉宁单组份的制备方法
CN114112612A (zh) * 2021-10-28 2022-03-01 丽珠集团福州福兴医药有限公司 一种替考拉宁i5杂质的分离纯化方法及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1496386A (en) * 1975-03-05 1977-12-30 Lepetit Spa Antibiotics

Also Published As

Publication number Publication date
SG70686G (en) 1987-07-03
DE3320342C2 (xx) 1991-07-11
FI73697C (fi) 1987-11-09
DK159117B (da) 1990-09-03
KR840005170A (ko) 1984-11-05
JPS591423A (ja) 1984-01-06
CH657139A5 (fr) 1986-08-15
PT76831A (en) 1983-07-01
PT76831B (en) 1986-04-09
DE3320342A1 (de) 1983-12-08
UA6025A1 (uk) 1994-12-29
LU84853A1 (fr) 1984-03-07
GB2121401B (en) 1985-09-18
ES536770A0 (es) 1985-08-16
ES8503689A1 (es) 1985-04-01
JPH0224278B2 (xx) 1990-05-29
DK245883A (da) 1983-12-09
SE8303211D0 (sv) 1983-06-07
JPH0415238B2 (xx) 1992-03-17
JPH02291279A (ja) 1990-12-03
US4542018A (en) 1985-09-17
HU193538B (en) 1987-10-28
FI73697B (fi) 1987-07-31
FI831660A0 (fi) 1983-05-12
ES522941A0 (es) 1985-04-01
CA1208204A (en) 1986-07-22
AU560966B2 (en) 1987-04-30
ES8506748A1 (es) 1985-08-16
IE831329L (en) 1983-12-08
GR78267B (xx) 1984-09-26
FI831660L (fi) 1983-12-09
JPH0415237B2 (xx) 1992-03-17
NO159104C (no) 1988-11-30
NO159104B (no) 1988-08-22
SU1318170A3 (ru) 1987-06-15
MY8700002A (en) 1987-12-31
IE55025B1 (en) 1990-04-25
IT1212085B (it) 1989-11-08
GB2121401A (en) 1983-12-21
JPH02291278A (ja) 1990-12-03
HK55887A (en) 1987-08-07
PH19533A (en) 1986-05-20
NO831754L (no) 1983-12-09
JPH0517237B2 (xx) 1993-03-08
AU1496883A (en) 1983-12-15
FR2528050B1 (fr) 1987-03-20
BG60529B2 (bg) 1995-07-28
IL68819A0 (en) 1983-09-30
GB8315003D0 (en) 1983-07-06
JPH02288887A (ja) 1990-11-28
JPH0517236B2 (xx) 1993-03-08
FR2528050A1 (fr) 1983-12-09
NL8301980A (nl) 1984-01-02
NZ204480A (en) 1986-04-11
SE459094B (sv) 1989-06-05
IT8321432A0 (it) 1983-06-02
SE8303211L (sv) 1983-12-09
KR900008246B1 (ko) 1990-11-06
ZA833607B (en) 1984-03-28
DK245883D0 (da) 1983-05-31
BE896993A (fr) 1983-12-07
JPH02288888A (ja) 1990-11-28

Similar Documents

Publication Publication Date Title
DK159117C (da) Fremgangsmaade til fremstilling af de rene enkeltfaktorer 1, 2, 3, 4 og 5 af teichomycin a2 eller farmaceutisk acceptable salte deraf
DK157031C (da) Fremgangsmaade til fremstilling af 4'-demethyl-epipodophyllotoxin-beta-d-ethylidenglycocid og acylderivater deraf til anvendelse som udgangsmaterialer i fremgangsmaaden
DK577084D0 (da) 2,2'iminobisethanol-derivater og fremgangsmaade til fremstilling deraf
DK181983D0 (da) 1,8-naphthyridin- og 1,5,8-azanaphthyridin-derivater, fremgangsmade til deres fremstilling samt deres anvendelse
DK410483D0 (da) Vaevsprotese og fremgangsmade til fremstilling af samme
DK332983D0 (da) Derivater af morpholinyldaunorubicin og morpholinyldoxorubicin og analoge deraf samt fremgangsmade til fremstilling deraf
DK397387A (da) Carbostyrilderivater og salte deraf samt fremgangsmaade til fremstilling af saadanne forbindelser
DK161968C (da) Analogifremgangsmaade til fremstilling af imidazo-pyrazolo-pyrimidiner eller farmaceutisk acceptable salte deraf
DK163181C (da) Analogifremgangsmaade til fremstilling af n,n'-di(arylalkylen)alkylendiaminer eller farmaceutisk acceptable salte deraf
DK149856C (da) Fremgangsmaade til fremstilling af 1,3-di- eller 1,3,8-trisubstituerede xanthiner eller fysiologisk acceptable salte deraf
DK146160C (da) Analogifremgangsmaade til fremstilling af n-(5-tetrazolyl)-4-oxo-4h-pyrimido(2,1-b)benzothiazol-3-carboxamider eller farmaceutisk acceptable salte deraf med baser
DK160150C (da) Benzothiazinderivater, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater indeholdende samme
DK161699C (da) Analogifremgangsmaade til fremstilling af 4-aryl-4-piperidincarbinoler eller farmaceutisk acceptable salte deraf
DK413883A (da) Fremgangsmaade til fremstilling af c-20-modificerede macrolidderivater eller farmaceutisk acceptable salte deraf
DK159853C (da) Analogifremgangsmaade til fremstilling af 9-dihydro-11,12-o-isopropyliden-erythromycin a eller -4ae-epi-erythromycin a eller 2'-o-acylater deraf eller farmaceutisk acceptable syreadditionssalte deraf
DK132883D0 (da) Fremgangsmade til fremstilling af a 41030-kompleks eller enkelte faktorer eller salte deraf samt mikroorganisme til anvendelse herved
DK85183A (da) Fremgangsmaade til fremstilling af benzokondenserede tricycliske forbindelser eller farmaceutisk acceptable salte deraf og mellemprodukter derved
DK586284D0 (da) Quinoloncarboxylsyre-derivater, fremgangsmaade til fremstilling deraf samt anvendelse af saadanne derivater som laegemiddel
DK147918C (da) Analogifremgangsmaade til fremstilling af thymosin alfa1 (18 - 28) eller farmaceutisk acceptable salte deraf
ES550824A0 (es) Procedimiento para preparar 12-amino-piridazino(4',5':3,4)- pirrolo(2,1-a)isoquinoleinas
DK398283A (da) Fremgangsmaade til fremstilling af 1,4-dihydropyridinderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK141383A (da) Substituerede 3,4-diamino-1,2,5-thiadiazoler og fremgangsmaade til fremstilling deraf
DK157025C (da) Analogifremgangsmaade til fremstilling af 4h-furo(3,2-b)indoler eller farmaceutisk acceptable salte deraf
DK163300C (da) Analogifremgangsmaade til fremstilling af fluorerede alkandiaminderivater eller pharmaceutisk acceptable salte deraf
DK346181A (da) Fremgangsmaade til fremstilling af pyrazolobenzazepiner eller farmaceutisk acceptable salte deraf

Legal Events

Date Code Title Description
PUP Patent expired